Search Results - "Riebling, Peter"

Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers by Wang, Michael L, Barrientos, Jacqueline C, Furman, Richard R, Mei, Matthew, Barr, Paul M, Choi, Michael Y, de Vos, Sven, Kallam, Avyakta, Patel, Krish, Kipps, Thomas J, Rule, Simon, Flanders, Kate, Jessen, Katti A, Ren, Hong, Riebling, Peter C, Graham, Patricia, King, Lydia, Thurston, Archie W, Sun, Michael, Schmidt, Elizabeth M, Lannutti, Brian J, Johnson, David M, Miller, Langdon L, Spurgeon, Stephen E

“…Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers In a Phase 1 trial, patients with refractory lymphoid cancers, an antibody-drug complex…”
Get more information

Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation by Weetall, Marla, Davis, Thomas, Elfring, Gary, Northcutt, Valerie, Cao, Liangxian, Moon, Young-Choon, Riebling, Peter, Dali, Mandar, Hirawat, Samit, Babiak, John, Colacino, Joseph, Almstead, Neil, Spiegel, Robert, Peltz, Stuart W.

“…PTC299 is a novel small molecule that specifically blocks the production of protein from selected mRNAs that under certain conditions use noncanonical…”
Get full text

Design of a Phase 3 Trial to Evaluate the Long-Term Efficacy and Safety of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (P2.329) by Trifillis, Panayiota, Riebling, Peter, O’Mara, Edward, Luo, Xiaohui, McIntosh, Joseph

“…Abstract only…”
Get full text

Slope Analysis of 6-Minute Walk Dstance as an Alternative Method to Determine Treatment Effect in Trials in Duchenne Muscular dystrophy (P2.331) by Trifillis, Panayiota, Riebling, Peter, Souza, Marcio, Elfring, Gary, Luo, Xiaohui, McIntosh, Joseph, Peltz, Stuart

“…Abstract only…”
Get full text

VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma by Wang, Michael, Barrientos, Jacqueline C., Furman, Richard R., Mei, Matthew, Barr, Paul M., Choi, Michael Y., de Vos, Sven, Kallam, Avyakta, Patel, Krish, Rule, Simon, Flanders, Kate, Jessen, Katti A., Riebling, Peter C., Graham, Patricia, King, Lydia, Schmidt, Elizabeth M., Lannutti, Brian J., Johnson, David M., Miller, Langdon L., Spurgeon, Stephen E.

“…Introduction: Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an oncofetal protein that is physiologically expressed during embryogenesis, largely…”
Get full text

Ataluren Confirmatory Trial in DMD: Effect of Ataluren on Activities of Daily Living in Nonsense Mutation Duchenne Muscular Dystrophy (P5.002) by Quinlivan, Ros, Luo, Xiaohui, Elfring, G., Kroger, Hans, Riebling, Peter, Ong, Tuyen, Spiegel, Robert, Peltz, Stuart, Kirschner, Jan

“…Abstract only…”
Get full text

Results of North Star Ambulatory Assessments (NSAA) in the Phase 3 Ataluren Confirmatory Trial in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD) (S28.002) by Bushby, Katharine, Kirschner, Jan, Luo, Xiaohui, Elfring, Gary, Kroger, Hans, Riebling, Peter, Ong, Tuyen, Spiegel, Robert, Peltz, Stuart, Muntoni, Francesco

“…Abstract only…”
Get full text

Results of North Star Ambulatory Assessments (NSAA) in the Phase 3 Ataluren Confirmatory Trial in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD) (I15.008) by Bushby, Katharine, Kirschner, Jan, Luo, Xiaohui, Elfring, Gary, Kroger, Hans, Riebling, Peter, Ong, Tuyen, Spiegel, Robert, Peltz, Stuart, Muntoni, Francesco

“…Abstract only…”
Get full text

ACT DMD: Effect of Ataluren on Timed Function Tests (TFTs) in Nonsense Mutation Duchenne Muscular Dystrophy (P3.163) by Goemans, Nathalie, Campbell, Craig, McDonald, Craig, Voit, Thomas, Luo, Xiaohui, Elfring, Gary, Kroger, Hans, Riebling, Peter, Ong, Tuyen, Spiegel, Robert, Peltz, Stuart, Bushby, Katharine

“…Abstract only…”
Get full text

Use of the Six-Minute Walk Distance (6MWD) Across Duchenne Muscular Dystrophy (DMD) Studies (P3.121) by McDonald, Craig, Sweeney, H. Lee, Luo, Xiaohui, Elfring, Gary, Kroger, Hans, Riebling, Peter, Ong, Tuyen, Spiegel, Robert, Peltz, Stuart, Mercuri, Eugenio

“…Abstract only…”
Get full text

Meta-Analysis of Deflazacort vs Prednisone/Prednisolone in Patients with Duchenne Muscular Dystrophy (P2.325) by Darras, Basil, Riebling, Peter, O’Mara, Edward, Elfring, Gary, Luo, Xiaohui, Trifillis, Panayiota, McIntosh, Joseph, Santos, Claudio, Parsons, Julie, Shieh, Perry B., Apkon, Susan, Campbell, Craig, McDonald, Craig

“…Abstract only…”
Get full text

Ataluren: An Overview of Clinical Trial Results in Nonsense Mutation Duchenne Muscular Dystrophy (P3.162) by McDonald, Craig, Bushby, Katharine, Tulinius, Mar, Finkel, Richard, Topaloglu, Haluk, Day, John, Flanigan, Kevin, Lowes, Linda, Eagle, Michelle, Luo, Xiaohui, Elfring, Gary, Kroger, Hans, Riebling, Peter, Ong, Tuyen, Spiegel, Robert, Peltz, Stuart, Kirschner, Jan

“…Abstract only…”
Get full text

Safety and Tolerability of Ataluren in a Phase 3 Study of Patients with Nonsense Mutation Duchenne Muscular Dystrophy (P3.164) by Campbell, Craig, Shieh, Perry, Sejersen, Thomas, Luo, Xiaohui, Elfring, Gary, Kroger, Hans, Riebling, Peter, Ong, Tuyen, Spiegel, Robert, Peltz, Stuart, Wong, Brenda

“…Abstract only…”
Get full text